| Name | | |
| Last NAV | 56.56 | 21.18 |
| Date of Valuation | 2025/11/20 | 2025/11/20 |
| Sharpe Ratio | N/A | 0.56 |
| 3-Year Risk Return Ratio | 1.11 | 0.54 |
| Cumulative Performance (%) |
| +7.34% | +6.72% |
| +31.75% | +7.76% |
| +57.99% | +17.18% |
| +44.10% | +16.97% |
| +17.29% | +16.40% |
| -17.36% | +47.30% |
| +33.53% | -2.30% |
| +465.60% | -24.25% |
| Calendar Year Performance (%) |
| +17.29% | +16.40% |
| -12.51% | +32.70% |
| -17.36% | +47.30% |
| +27.52% | -32.30% |
| +33.53% | -2.30% |
| 3-Year Annualised Volatility | 18.48% | 15.14% |
| Funds House | Franklin Templeton Investments (Asia) Ltd | Schroder Investment Management (Hong Kong) Limited |
| Portfolio Manager | Evan McCulloch & Wendy Lam & Akiva Felt | Felix Odey & Alex Monk & Mark Lacey |
| Funds Type | Equity Funds | Equity Funds |
| Funds Size | USD 1590000000 | USD 345190000 |
| Base Currency | USD | USD |
| Sector | Biotechnology | Energy |
| Geographic Allocation | US | Global |
| Top Holdings |
| AMGEN INC (8.16%) | Coterra Energy Inc (4.80%) |
| REGENERON PHARMACEUTICALS INC (7.13%) | BP PLC (3.90%) |
| VERTEX PHARMACEUTICALS INC (5.83%) | John Wood Group PLC (3.30%) |
| INSMED INC (3.82%) | Equinor ASA (3.20%) |
| GILEAD SCIENCES INC (3.69%) | Technip Energies NV (3.70%) |
| ASTRAZENECA PLC (2.92%) | Shell PLC (3.50%) |
| INTRA-CELLULAR THERAPIES INC (2.84%) | Repsol SA (5.00%) |
| BIOGEN INC (2.74%) | Eni SpA (3.60%) |
| MERUS NV (2.73%) | Schlumberger NV (3.80%) |
| ARGENX SE (2.68%) | Baker Hughes Co (3.40%) |
| Minimum Initial Investment | USD 1000 | USD 1000 |
| Initial Sales Fee | Class A: Up to 5.00%. Class B: Nil | A and AX Shares up to 5.00% of the total subscription amount (equivalent to 5.26315% of the Net Asset Value per Share) |
| Switching Fee | Class A: 1.00%. Class B: Nil | The Directors may, at their discretion, allow certain selected Distributors to make a charge for switching which shall not exceed 1% of the value of the Share being requested to be switched. |
| Maintenance Fee | Custodian fee Class A: Up to 0.14% ( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Custodian fee Class B: Up to 0.14%( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Maintenance charge Class A: Up to 0.50%. Maintenance charge Class B: Up to 0.75%. Servicing charge Class A: Nil. Servicing charge Class B: 1.06%. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class A: Up to 0.2175%, Up to USD 30 per annum. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class B: Up to 0.2175%, Up to USD 30 per annum. | Custodian fee:up to a maximum of 0.5% per annum and USD 150 per transaction respectively.Fees relating to core fund accounting and valuation services：up to 0.02% of the Net Asset Value of a Fund,subject to an annual minimum fee of USD 20,000. |
| Redemption Fee | Class A: Nil. Class B: Up to 4.00% | At the time of this Prospectus, there are no Funds to which such a redemption charge is applicable. |
| Launch Date | 2000/04/03 | 2006/06/30 |
| End of Financial Year | 30/06 | 31/12 |
| Country of Registry | Luxembourg | Luxembourg |
| Other Relevant Information | | |
| |